Muscular Dystrophy

This is a group of inherited diseases that cause muscles to weaken and waste away over time. It's usually present from birth or early childhood. The specific type depends on the gene involved, leading to different patterns of muscle weakness.

Condition

What people with Muscular Dystrophy report

Every report comes from a Lived member, sent anonymously.

Have you tried Prednisone for Muscular Dystrophy?

NameHow it went

About Muscular Dystrophy

What It Is

Muscular dystrophy is a group of more than 30 genetic diseases in which muscles gradually weaken and lose bulk. Over time the weakness can make walking, lifting, climbing stairs and other daily activities harder. Some types also affect the heart, the muscles used for breathing and swallowing, or other organs, which is why care usually involves more than a neurologist. The types differ a great deal in which muscles they affect first, when they start and how quickly they progress. Duchenne muscular dystrophy is the most common childhood form: it mainly affects boys, usually shows up between ages 3 and 6, and is severe. Becker muscular dystrophy involves the same gene but is milder and slower. Myotonic dystrophy is the most common form that begins in adulthood, often in a person's twenties or thirties; along with weakness, it causes myotonia (difficulty relaxing a muscle, such as letting go of a door handle) and can cause cataracts, heart rhythm problems and diabetes. Facioscapulohumeral muscular dystrophy first affects the face, shoulders and upper arms, while congenital forms are present at birth or in the first two years. Even people with the same type can have quite different symptoms.

Causes & Risk Factors

Muscular dystrophy is caused by changes (variants or mutations) in genes that make proteins muscles need to stay strong and repair themselves. Without enough of a working protein, muscle fibers are damaged during ordinary use and are gradually replaced by fat and scar tissue. Duchenne and Becker muscular dystrophy, for example, result from changes in the gene for dystrophin, a protein that helps hold muscle cells together. How a type is inherited affects who in a family may be at risk. Duchenne and Becker are X-linked: the gene is on the X chromosome, so they mainly affect boys, while girls and women who carry the change are usually less affected but can develop heart muscle problems. Myotonic dystrophy and facioscapulohumeral muscular dystrophy are autosomal dominant, so one changed copy from either parent can cause the condition. Many families have a history of the disease, but a person can also be the first in the family to have it. Nothing a person or parent did causes muscular dystrophy, and activity or injury does not bring it on.

How It's Diagnosed

Evaluation often starts when a child seems clumsy, falls often, walks on their toes, has trouble climbing stairs or uses their hands to push up from the floor, or when an adult notices weakness, grip problems or muscle stiffness. A clinician takes a detailed medical and family history and examines which muscles are weak. A blood test for creatine kinase (CK), an enzyme that leaks out of damaged muscle, is often an early clue; in Duchenne it is usually very high. Damaged muscle can also raise liver-type enzymes, which sometimes sends families down the wrong path toward a liver problem. Genetic testing usually confirms the specific type and gene change, which matters because some treatments work only for particular changes. When genetic results are unclear, a muscle biopsy can show whether key muscle proteins are missing. Electromyography (EMG) and nerve conduction studies, which measure how muscles and nerves respond to electrical signals, and muscle MRI help separate muscular dystrophy from nerve diseases and other muscle conditions. Because several types affect the heart and breathing, diagnosis is typically followed by baseline heart tests, such as an electrocardiogram (ECG) and an echocardiogram or cardiac MRI, and breathing tests. Genetic counseling helps relatives understand their own risk; female relatives of someone with Duchenne are usually offered carrier testing.

Treatment Options

There is no cure for muscular dystrophy, but treatment can preserve strength and function for longer, prevent complications and extend life. Care is usually coordinated by a neuromuscular specialist with a team. Physical therapy and stretching help keep muscles flexible and limit contractures (joints that become fixed in a bent position). Occupational therapy and devices such as braces, walkers and wheelchairs keep people independent and safe. Speech therapy can help with speech and swallowing problems. Surgery may be used for scoliosis (curving of the spine), tight joints or cataracts. Heart and breathing care are central for many types. Medicines normally used for heart failure, such as ACE inhibitors and beta blockers, are started early in Duchenne to protect the heart muscle. As breathing muscles weaken, cough-assist devices and noninvasive ventilation (a mask-based breathing machine, often used first at night) reduce chest infections and prolong life. In myotonic dystrophy, some people need a pacemaker or implanted defibrillator because of heart rhythm problems. Duchenne has the most disease-specific options. Corticosteroids are the long-standing mainstay: they slow muscle loss, help children keep walking for longer and protect arm and breathing strength. Options include prednisone, deflazacort (Emflaza) and vamorolone (Agamree), and the choice involves trade-offs such as weight gain, slowed growth, bone thinning and mood changes. Long-term steroids should never be stopped suddenly, because the body may not make enough of its own stress hormone, which can cause a life-threatening adrenal crisis; families usually receive a plan for extra doses during serious illness or surgery. Givinostat (Duvyzat) is an oral nonsteroid medicine approved for people with Duchenne age 6 and older. Exon-skipping drugs, such as eteplirsen (Exondys 51), are weekly infusions for people whose gene change fits a specific drug; they were approved because they raise dystrophin levels, and whether they improve function is still being confirmed. A one-time gene therapy, delandistrogene moxeparvovec (Elevidys), is approved for people with Duchenne who are age 4 or older and can still walk; it has caused serious and sometimes fatal liver injury, so it requires careful screening and close liver monitoring afterward. Clinical trials are an option for many types.

What to Expect

Muscular dystrophy usually progresses, but the pace depends heavily on the type. Some people with milder forms walk and work throughout adult life with modest limits, while Duchenne typically leads to wheelchair use in late childhood or the teen years, with breathing and heart involvement growing over the following decade. With modern care, many people with Duchenne now live into their 30s and beyond, and attention has shifted to education, work, independence and relationships as well as medical care. Regular follow-up does much of the protective work. Breathing strength can decline and heart function can weaken without obvious symptoms, especially once a person no longer walks and exertion is limited, so lung function tests, sleep studies, ECGs and heart imaging are scheduled routinely rather than waiting for problems. Yearly flu shots and pneumococcal vaccines help prevent chest infections. Bone health, weight, swallowing, nutrition and mental health are also monitored, particularly in people taking steroids. Daily life often involves adapting the home, school or workplace, planning for mobility equipment and coordinating many appointments. Caregivers can carry a heavy load, and patient organizations, social workers and specialized neuromuscular clinics can help with equipment, benefits, transition from pediatric to adult care and connection with other families.

When to Seek Help

Arrange an evaluation if a child has delayed walking, frequent falls, toe walking, trouble climbing stairs or getting up from the floor, or if an adult develops steadily increasing weakness or difficulty relaxing a grip. People with a known muscular dystrophy should tell the care team about morning headaches, poor sleep, daytime sleepiness, a weakening cough, new swallowing trouble, swelling in the legs or growing breathlessness, since these can be early signs of breathing or heart decline. Contact the care team promptly for fainting, near fainting or a pounding or irregular heartbeat, which in myotonic dystrophy can signal a dangerous heart rhythm problem, and for any chest infection, which can become serious quickly when cough is weak. Before any surgery or sedation, make sure the anesthesia team knows the diagnosis, because certain anesthetic drugs can trigger severe muscle breakdown and dangerous potassium levels. Call 911 if someone with Duchenne becomes confused, has trouble breathing or a racing heart after a fall or broken leg, as this can signal fat embolism, a rare but life-threatening complication. Someone taking long-term steroids who is vomiting, unable to take their dose or becomes very weak or drowsy during an illness needs their emergency steroid plan and urgent medical care.

Questions to Ask Your Doctor

  1. 1.Which type of muscular dystrophy is this, and what does the specific gene change mean for how it is likely to progress?
  2. 2.How often should heart and breathing tests be done, and what results would change the plan?
  3. 3.Which treatments, including steroids, newer medicines or clinical trials, fit this type and stage, and what trade-offs should we expect?
  4. 4.Should other family members have genetic counseling or testing?
  5. 5.What equipment, therapy and school or workplace support should we arrange now to stay ahead of changes?

Last reviewed • Oct 2026

Educational content, not medical advice.